.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Deloitte
Merck
Harvard Business School
Julphar
Fuji
Cantor Fitzgerald
Medtronic
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

PANTOPRAZOLE SODIUM - Generic Drug Details

« Back to Dashboard

What are the generic sources for pantoprazole sodium and what is the scope of pantoprazole sodium freedom to operate?

Pantoprazole sodium
is the generic ingredient in three branded drugs marketed by Jubilant Generics, Apotex Inc, Amneal Pharms, Dr Reddys Labs Ltd, Wyeth Pharms Inc, Macleods Pharms Ltd, Perrigo R And D, Wockhardt, Aurobindo Pharma Ltd, Orchid Hlthcare, Teva, Sun Pharm Inds Ltd, Mylan Pharms Inc, Torrent Pharms, Kremers Urban Pharms, Hetero Labs Ltd V, Sandoz Inc, Akorn Inc, and Actavis Totowa, and is included in twenty-three NDAs. There are nine patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Pantoprazole sodium has one hundred and one patent family members in forty-seven countries.

There are forty-six drug master file entries for pantoprazole sodium. Fifty-eight suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: PANTOPRAZOLE SODIUM

Tradenames:3
Patents:9
Applicants:19
NDAs:23
Drug Master File Entries: see list46
Suppliers / Packagers: see list58
Bulk Api Vendors: see list105
Clinical Trials: see list2,466
Patent Applications: see list6,034
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:PANTOPRAZOLE SODIUM at DailyMed

Pharmacology for Ingredient: PANTOPRAZOLE SODIUM

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors

Tentative approvals for PANTOPRAZOLE SODIUM

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe40MGINJECTABLE; INJECTION
► Subscribe► SubscribeEQ 40MG BASE/VIALINJECTABLE; IV (INFUSION)
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
PANTOPRAZOLE SODIUM
pantoprazole sodium
INJECTABLE;IV (INFUSION)205675-001Mar 30, 2016APRXNoNo► Subscribe► Subscribe
Wockhardt
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL091231-001Jan 19, 2011ABRXNoNo► Subscribe► Subscribe
Orchid Hlthcare
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL202052-001Dec 2, 2014ABRXNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
PROTONIX IV
pantoprazole sodium
INJECTABLE;IV (INFUSION)020988-001Mar 22, 2001APRXYesYes6,780,881*PED► SubscribeY► Subscribe
Kremers Urban Pharms
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL078281-001Jan 20, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pantoprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 20015,997,903*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-001Feb 2, 20004,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
FOR SUSPENSION, DELAYED RELEASE;ORAL022020-001Nov 14, 20074,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 20014,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX IV
pantoprazole sodium
INJECTABLE;IV (INFUSION)020988-001Mar 22, 20014,758,579*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: pantoprazole sodium

Country Document Number Estimated Expiration
Slovakia287993► Subscribe
South Africa9204386► Subscribe
EcuadorSP034613► Subscribe
Estonia200300182► Subscribe
Peru05822002► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PANTOPRAZOLE SODIUM

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/056United Kingdom► SubscribePRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604
C0032Belgium► SubscribePRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Daiichi Sankyo
US Army
Harvard Business School
Medtronic
Moodys
Teva
Farmers Insurance
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot